綠康生化(002868.SZ):2021年度擬申請總額不超3.6億元綜合授信額度
格隆匯 11 月 27日丨綠康生化(002868.SZ)公佈,公司於2020年11月27日召開第三屆董事會第二十二次(臨時)會議和第三屆監事會第二十次會議審議通過了《關於2021年度向銀行等金融機構申請綜合授信額度的議案》,公司獨立董事就此事項發表了同意意見,現將相關情況公告如下:
根據日常生產經營所需,公司及子公司福建綠安生物農藥有限公司(“綠安生物”)、二級子公司福建綠家生物科技有限公司(“綠家生物”)擬向銀行等金融機構申請總額不超過人民幣3.6億元的綜合授信額度,其中:公司擬向銀行等金融機構申請總額不超過人民幣3.3億元的綜合授信額度,子公司綠安生物擬向銀行等金融機構申請總額不超過人民幣2000萬元的綜合授信額度,二級子公司綠家生物擬向銀行等金融機構申請總額不超過人民幣1000萬元的綜合授信額度。公司、綠安生物及綠家生物實際融資金額應在授信額度內,以實際發生的融資金額為準。
公司、綠安生物及綠家生物授權其法定代表人與銀行等金融機構簽署上述授信融資項下的有關法律文件,由此產生的法律、經濟責任分別由公司、綠安生物及綠家生物承擔。
根據《深圳證券交易所股票上市規則》及《公司章程》相關規定,上述向銀行等金融機構申請綜合授信額度無需提交公司股東大會審議批准,以上授權期限為2021年1月1日至2021年12月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.